Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

Inclusion Criteria:

1. Is a healthy Chinese male.
2. Has not had sexual debut at the time of enrollment, and does not plan on becoming sexually active during the vaccination period (Day 1 through one month post last dose).

Exclusion Criteria:

1. Has a history of known prior vaccination with an HPV vaccine.
2. Has a history of HPV-related external genital lesions, HPV-related intra-anal lesions, or HPV-related head and neck cancer.
3. Has a history of severe allergic reaction that required medical intervention.
4. Has received immune globulin or blood-derived products in the past 6 months or plans to receive any before one month post last dose.
5. Has a history of splenectomy, is currently immunocompromised, or has been diagnosed with immunodeficiency, human immunodeficiency virus (HIV), lymphoma, leukemia, systemic lupus erythematosus, rheumatoid arthritis, juvenile rheumatoid arthritis, inflammatory bowel disease, or other autoimmune condition.
6. Has received immunosuppressive therapy in the past year, excluding inhaled, nasal, or topical corticosteroids and certain regimens of systemic corticosteroids.
7. Has a known thrombocytopenia or coagulation disorder that would contraindicate IM injections.